• Vifor Pharma and Akebia to sell Vadadustat to Fresenius Medical Care pharmaceutical-technology
    May 18, 2017
    Vifor Pharma Group and Akebia Therapeutics have entered an exclusive license agreement to sell Vadadustat to Fresenius Medical Care dialysis clinics located in the US after securing approval from the US Food and Drug Administration (FDA).
PharmaSources Customer Service